Trials that use: Multiple imputation / missing data
New to this method? Read the tutorial →
7,624 results
- Assessment of Pharmacokinetics of Single Dose Odanacatib (MK-0822) in Participants With Moderate Hepatic Insufficiency (MK-0822-070): Complete Statistical AnalysisIndependent statistical analysis of Assessment of Pharmacokinetics of Single Dose Odanacatib (MK-0822) in Participants With Moderate Hepatic Insufficiency (MK-0822-070): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Assessment of Physical Functioning and Handling of Spiolto Respimat in Patients With COPD (OTIVACTO): Complete Statistical AnalysisIndependent statistical analysis of Assessment of Physical Functioning and Handling of Spiolto Respimat in Patients With COPD (OTIVACTO): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Assessment of the Effect of PAP on Energy and Vitality in Mild OSA Patients: The Merge Study: Complete Statistical AnalysisIndependent statistical analysis of Assessment of the Effect of PAP on Energy and Vitality in Mild OSA Patients: The Merge Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Assessment of the Long-Term Safety and Efficacy of Bempedoic Acid (CLEAR Harmony OLE): Complete Statistical AnalysisIndependent statistical analysis of Assessment of the Long-Term Safety and Efficacy of Bempedoic Acid (CLEAR Harmony OLE): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Assessment of the Safety and the Performance of the SAGITTA EVL R Stems in Hip Arthroplasties: Complete Statistical AnalysisIndependent statistical analysis of Assessment of the Safety and the Performance of the SAGITTA EVL R Stems in Hip Arthroplasties: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Assessment of the Safety of Adalimumab in Rheumatoid Arthritis Patients Showing Rapid Progression of Structural Damage of the Joints, Who Have no Prior History of Treatment With Disease-modifying Anti-rheumatic Drugs or Biological Agents: Complete Statistical AnalysisIndependent statistical analysis of Assessment of the Safety of Adalimumab in Rheumatoid Arthritis Patients Showing Rapid Progression of Structural Damage of the Joints, Who Have no Prior History of Treatment With Disease-modifying…
- Assessment of Two New Electronic Cigarettes in Cigarette Smokers: Complete Statistical AnalysisIndependent statistical analysis of Assessment of Two New Electronic Cigarettes in Cigarette Smokers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03435562).
- ASSISTIndependent statistical analysis of AsseSSing Impact in pSoriatic Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05171270).
- ASSIST-RTIndependent statistical analysis of GP2013 Treatment in Patients With Active Rheumatoid Arthritis, Previously Treated With Rituxan® or MabThera®: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Associated Factors in Perioperative Hypoglycemia in Patients With Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Associated Factors in Perioperative Hypoglycemia in Patients With Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00826007).
- Association of Beta-2 Adrenergic Agonist and Corticosteroid Injection in the Treatment of Lipomas: Complete Statistical AnalysisIndependent statistical analysis of Association of Beta-2 Adrenergic Agonist and Corticosteroid Injection in the Treatment of Lipomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- ASSUREIndependent statistical analysis of A Simplification Study of Unboosted Reyataz With Epzicom (ASSURE): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01102972).
- ASSUREIndependent statistical analysis of Absorption and Safety With Sustained Use of RELiZORB Evaluation (ASSURE) Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- AST-VAC2 Vaccine in Patients With Non-small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of AST-VAC2 Vaccine in Patients With Non-small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03371485).
- ASTCIndependent statistical analysis of Antibacterial-coated Sutures at Time of Cesarean: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03386240).
- AstellasIndependent statistical analysis of A Pilot Study Comparing the Use of Low-target Versus Conventional Target Advagraf: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- ASTEROID 1Independent statistical analysis of Bay1002670, Fibroids, Safety and Efficacy EU,US,Can, Jap: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02131662).
- AsthmaCareIndependent statistical analysis of Randomized Prospective Trial of a Mobile Health Application for Asthma Self-Management: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- ASTRAL-5Independent statistical analysis of Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV)-1 Coinfection: primary endpoint results,…
- At-Home Telehealth Yoga for Treating Chronic Pain in People With Alzheimer’s Disease and Their Caregiver’s: Complete Statistical AnalysisIndependent statistical analysis of At-Home Telehealth Yoga for Treating Chronic Pain in People With Alzheimer's Disease and Their Caregiver's: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Atacicept in Subjects With Optic Neuritis: Complete Statistical AnalysisIndependent statistical analysis of Atacicept in Subjects With Optic Neuritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00624468).
- ATALANTE-1Independent statistical analysis of OSE2101 Versus Chemotherapy in HLA-A2 Positive Patients With Advanced NSCLC After Immune Checkpoint Inhibitor Failure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- AtazanavirIndependent statistical analysis of Bioequivalence Study of Individual Atazanavir and Cobicistat Compared With Atazanavir in Fixed-dose Combination With Cobicistat: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Atazanavir Used in Combination With Other Anti-HIV Drugs in HIV-Infected Infants, Children, and Adolescents: Complete Statistical AnalysisIndependent statistical analysis of Atazanavir Used in Combination With Other Anti-HIV Drugs in HIV-Infected Infants, Children, and Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Atezolizumab and Bevacizumab in Combination With TACE for Patients With BCLC B HCC: Complete Statistical AnalysisIndependent statistical analysis of Atezolizumab and Bevacizumab in Combination With TACE for Patients With BCLC B HCC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Atezolizumab and Bevacizumab in Treating Patients With Recurrent, Persistent, or Metastatic Cervical Cancer: Complete Statistical AnalysisIndependent statistical analysis of Atezolizumab and Bevacizumab in Treating Patients With Recurrent, Persistent, or Metastatic Cervical Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Atezolizumab Before Surgery for the Treatment of Regionally Metastatic Head and Neck Squamous Cell Cancer With an Unknown or Historic Primary Site: Complete Statistical AnalysisIndependent statistical analysis of Atezolizumab Before Surgery for the Treatment of Regionally Metastatic Head and Neck Squamous Cell Cancer With an Unknown or Historic Primary Site: primary endpoint results, effect estimate with…
- Atezolizumab Immunotherapy in Patients With Advanced NSCLC: Complete Statistical AnalysisIndependent statistical analysis of Atezolizumab Immunotherapy in Patients With Advanced NSCLC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03102242).
- ATHENA-1Independent statistical analysis of A Open-label Study to Evaluate the Safety of TRV130 in Patients With Acute Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- ATLANTIndependent statistical analysis of Efficacy and Safety of Lanreotide Autogel (ATG) in Combination With Temozolomide in Subjects With Thoracic Neuroendocrine Tumors.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- ATLANTICIndependent statistical analysis of ATLANTIC (NCT01347580), a randomized phase 4 trial comparing pre-hospital versus in-hospital initiation of ticagrelor in STEMI patients planned for PCI.
- ATLASIndependent statistical analysis of Anxiety-mediated Impairments in Large Elastic Artery Function and the Autonomic Nervous System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- ATLASIndependent statistical analysis of Efficacy, Safety, and Pharmacokinetic Profile of Etokimab (ANB020) in Adult Participants With Moderate-to-Severe Atopic Dermatitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- ATNIndependent statistical analysis of Acute Renal Failure Trial Network (ATN) Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00076219).
- Atomoxetine and Huntington’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Atomoxetine and Huntington's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00368849).
- Atomoxetine to Treat Korean Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD): Complete Statistical AnalysisIndependent statistical analysis of Atomoxetine to Treat Korean Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Atomoxetine/Attention Deficit/ Hyperactive Disorder (ADHD)/Substance Use Disorder (SUD)in a Residential Treatment Facility: Complete Statistical AnalysisIndependent statistical analysis of Atomoxetine/Attention Deficit/ Hyperactive Disorder (ADHD)/Substance Use Disorder (SUD)in a Residential Treatment Facility: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Atorvastatin in Treating Patients With Stage IIb-III Triple Negative Breast Cancer Who Did Not Achieve a Pathologic Complete Response After Receiving Neoadjuvant Chemotherapy: Complete Statistical AnalysisIndependent statistical analysis of Atorvastatin in Treating Patients With Stage IIb-III Triple Negative Breast Cancer Who Did Not Achieve a Pathologic Complete Response After Receiving Neoadjuvant Chemotherapy: primary endpoint results, effect estimate…
- Atorvastatin Therapy for the Prevention of Atrial Fibrillation (SToP-AF): Complete Statistical AnalysisIndependent statistical analysis of Atorvastatin Therapy for the Prevention of Atrial Fibrillation (SToP-AF): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00252967).
- Atovaquone and Azithromycin Combination for Confirmed COVID-19 Infection: Complete Statistical AnalysisIndependent statistical analysis of Atovaquone and Azithromycin Combination for Confirmed COVID-19 Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04339426).
- Atralin Gel for the Treatment of Rosacea: Complete Statistical AnalysisIndependent statistical analysis of Atralin Gel for the Treatment of Rosacea: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01125930).
- Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE A): Complete Statistical AnalysisIndependent statistical analysis of Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE A): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- ATTIndependent statistical analysis of Aquatic Treadmill Therapy for Improving Gait, Balance, Fitness and Quality of Life in Stroke Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Attachment Based Family Therapy for Suicidal Adolescents: Complete Statistical AnalysisIndependent statistical analysis of Attachment Based Family Therapy for Suicidal Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01537419).
- Attain Performa(TM) Quadripolar Lead Study: Complete Statistical AnalysisIndependent statistical analysis of Attain Performa(TM) Quadripolar Lead Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01751022).
- Attain Success Clinical Trial: Complete Statistical AnalysisIndependent statistical analysis of Attain Success Clinical Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00990964).
- Attention Bias Modification Training for Young People: Complete Statistical AnalysisIndependent statistical analysis of Attention Bias Modification Training for Young People: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02270671).
- ATTRACTIndependent statistical analysis of Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00790335).
- ATTRibute-CMIndependent statistical analysis of Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Audiobooks for Hearing Loss App as Auditory Training: Complete Statistical AnalysisIndependent statistical analysis of Audiobooks for Hearing Loss App as Auditory Training: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04231396).